300858.SZ
科拓生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.55
−5.52%Margins
Gross margin
50.4%
EBITDA margin
37.0%
EBIT margin
25.8%
Net margin
23.9%
FCF margin
-27.6%
4.8%
Return on equity
4.4%
Return on assets
5.2%
Return on invested capital
0.18x
Asset turnover
CNY 131.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026